Rankings
▼
Calendar
ENGN Q4 2025 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena
ENGN
enGene Holdings Inc.
$359M
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$171,000
Operating Income
-$39M
Net Income
-$38M
EPS (Diluted)
$-0.74
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$25M
Free Cash Flow
-$25M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$221M
Total Liabilities
$54M
Stockholders' Equity
$168M
Cash & Equivalents
$50M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$480,000
-100.0%
Gross Profit
-$171,000
$240,000
-171.3%
Operating Income
-$39M
-$17M
-126.2%
Net Income
-$38M
-$15M
-147.6%
← FY 2025
All Quarters
Q1 2026 →